Top compounds associated with response to ZNF622


Feature Type Standardized
Nominal ANOVA
mRNA LE-135 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.01
mRNA QL-XI-92 GDSC1000 pan-cancer AAC -0.076 0.01
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.093 0.01
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.01
mRNA tandutinib CTRPv2 pan-cancer AAC -0.09 0.01
mRNA AA-COCF3 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA lapatinib GDSC1000 pan-cancer AAC 0.12 0.01
mRNA SB52334 GDSC1000 pan-cancer AAC -0.08 0.02
mRNA WZ3105 GDSC1000 pan-cancer AAC -0.072 0.02
Download CSV